{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T20:05:49Z","timestamp":1780344349060,"version":"3.54.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Russian Foundation for Basic Research","award":["08-04-13626-ofi_c"],"award-info":[{"award-number":["08-04-13626-ofi_c"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochimie"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.biochi.2012.03.007","type":"journal-article","created":{"date-parts":[[2012,3,16]],"date-time":"2012-03-16T18:29:51Z","timestamp":1331922591000},"page":"1368-1375","source":"Crossref","is-referenced-by-count":7,"title":["Antiangiogenic and antivascular effects of a recombinant tumstatin-derived peptide in a corneal neovascularization model"],"prefix":"10.1016","volume":"94","author":[{"given":"Roman","family":"Esipov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ksenia","family":"Beyrakhova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Likhvantseva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgenia","family":"Stepanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasily","family":"Stepanenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Kostromina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulia","family":"Abramchik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anatoly","family":"Miroshnikov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biochi.2012.03.007_bib1","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0008-4182(05)80070-5","article-title":"Age-related macular degeneration: economic burden and value-based medicine analysis","volume":"40","author":"Brown","year":"2005","journal-title":"Can. J. Ophthalmol."},{"key":"10.1016\/j.biochi.2012.03.007_bib2","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1001\/jama.290.15.2057","article-title":"Important causes of visual impairment in the world today","volume":"290","author":"Congdom","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.biochi.2012.03.007_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.med.57.121304.131306","article-title":"Angiogenesis","volume":"57","author":"Folkman","year":"2006","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.biochi.2012.03.007_bib4","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1210\/edrv-13-1-18","article-title":"Molecular and biological properties of the vascular endothelial growth factor family of proteins","volume":"13","author":"Ferrara","year":"1992","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.biochi.2012.03.007_bib5","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.survophthal.2006.10.017","article-title":"Ocular neovascularization: basic mechanisms and therapeutic advances","volume":"52","author":"Dorrell","year":"2007","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.biochi.2012.03.007_bib6","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa054481","article-title":"Ranibizumab for neovascular age-related macular degeneration","volume":"355","author":"Rosenfeld","year":"2006","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.biochi.2012.03.007_bib7","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/j.ophtha.2006.05.064","article-title":"Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy","volume":"113","author":"Avery","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.biochi.2012.03.007_bib8","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1177\/019262339902700115","article-title":"Preclinical safety evaluation of rhuMAbVEGF, an antiangiogenic humanized monoclonal antibody","volume":"27","author":"Ryan","year":"1999","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.biochi.2012.03.007_bib9","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1200\/JCO.2005.10.017","article-title":"Bevacizumab in combination with fluorouracil and leucovorin: an active regimen for first-line metastatic colorectal cancer","volume":"23","author":"Hurwitz","year":"2005","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.biochi.2012.03.007_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2006.09.002","article-title":"Ocular neovascularization: implication of endogenous angiogenic inhibitors and potential therapy","volume":"26","author":"Zhang","year":"2007","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.biochi.2012.03.007_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrc.2007.01.123","article-title":"Molecular pathways of angiogenesis inhibition","volume":"355","author":"Tabruyn","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biochi.2012.03.007_bib12","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.bbrc.2005.05.130","article-title":"Tumstatin, the NC1 domain of alpha3 chain of type IV collagen, is an endogenous inhibitor of pathological angiogenesis and suppresses tumor growth","volume":"333","author":"Hamano","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biochi.2012.03.007_bib13","doi-asserted-by":"crossref","first-page":"23745","DOI":"10.1074\/jbc.C000186200","article-title":"Two RGD-independent alphavbeta3 integrin binding sites on tumstatin regulate distinct antitumor properties","volume":"275","author":"Maeshima","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.biochi.2012.03.007_bib14","doi-asserted-by":"crossref","first-page":"4766","DOI":"10.1073\/pnas.0730882100","article-title":"Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by alpha v beta 3 and alpha 5 beta 1 integrins","volume":"100","author":"Sudhakar","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1016\/j.biochi.2012.03.007_bib15","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1007\/s11095-008-9634-z","article-title":"Inhibition of tumor angiogenesis by tumstatin: insights into signaling mechanisms and implications in cancer regression","volume":"25","author":"Sudhakar","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.biochi.2012.03.007_bib16","doi-asserted-by":"crossref","first-page":"21340","DOI":"10.1074\/jbc.M001956200","article-title":"Distinct antitumor properties of a type IV collagen domain derived from basement membrane","volume":"275","author":"Maeshima","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.biochi.2012.03.007_bib17","first-page":"8","article-title":"Validation of different systems for tumstatin expression and its in-vitro and in-vivo activities","volume":"2009","author":"Boosani","year":"2010","journal-title":"Cancer Sci. Ther."},{"key":"10.1016\/j.biochi.2012.03.007_bib18","first-page":"560","article-title":"The immunogenicity of therapeutic proteins","volume":"9","author":"Schellekens","year":"2010","journal-title":"Discov. Med."},{"key":"10.1016\/j.biochi.2012.03.007_bib19","doi-asserted-by":"crossref","first-page":"31959","DOI":"10.1074\/jbc.M103024200","article-title":"Extracellular matrix-derived peptide binds to \u03b1v\u03b23 integrin and inhibits angiogenesis","volume":"276","author":"Maeshima","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.biochi.2012.03.007_bib20","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1042\/BA20100027","article-title":"Production of thymosin alpha1 via non-enzymatic acetylation of the recombinant precursor","volume":"56","author":"Esipov","year":"2010","journal-title":"Biotechnol. Appl. Biochem."},{"key":"10.1016\/j.biochi.2012.03.007_bib21","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.biochi.2012.03.007_bib22","doi-asserted-by":"crossref","first-page":"521","DOI":"10.4049\/jimmunol.144.2.521","article-title":"A\u00a0mouse lymphoid endothelial cell line immortalized by simian virus 40 binds lymphocytes and retains functional characteristics of normal endothelial cells","volume":"144","author":"O'Connell","year":"1990","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.biochi.2012.03.007_bib23","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nbt0293-187","article-title":"A\u00a0thioredoxin gene fusion expression system that circumvents inclusion body formation in the E.\u00a0coli cytoplasm","volume":"11","author":"LaVallie","year":"1993","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.biochi.2012.03.007_bib24","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1080\/08820530902800017","article-title":"Review of the ocular angiogenesis animal models","volume":"24","author":"Montezuma","year":"2009","journal-title":"Semin. Ophthalmol."},{"key":"10.1016\/j.biochi.2012.03.007_bib25","doi-asserted-by":"crossref","first-page":"13374","DOI":"10.1016\/S0021-9258(18)37714-7","article-title":"Identification of the Goodpasture antigen as the alpha 3(IV) chain of collagen IV","volume":"263","author":"Saus","year":"1988","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.biochi.2012.03.007_bib26","doi-asserted-by":"crossref","first-page":"20395","DOI":"10.1074\/jbc.272.33.20395","article-title":"A\u00a0cell binding domain from the a3 chain of type IV collagen inhibits proliferation of melanoma cells","volume":"272","author":"Han","year":"1997","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.biochi.2012.03.007_bib27","first-page":"467","article-title":"A\u00a0specific sequence of the noncollagenous domain of the a3(IV) chain of type IV collagen inhibits expression and activation of matrix metalloproteinases by tumor cells","volume":"60","author":"Pasco","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.biochi.2012.03.007_bib28","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1126\/science.1065298","article-title":"Tumstatin, an endothelial cell-specific inhibitor of protein synthesis","volume":"295","author":"Maeshima","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.biochi.2012.03.007_bib29","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1038\/aps.2009.111","article-title":"The anti-tumor properties of two tumstatin peptide fragments in human gastric carcinoma","volume":"30","author":"Li","year":"2009","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.biochi.2012.03.007_bib30","doi-asserted-by":"crossref","first-page":"11331","DOI":"10.1158\/0008-5472.CAN-06-1540","article-title":"The PTEN\/Akt pathway dictates the direct AVB3-dependent growth-inhibitory action of an active fragment of tumstatin in glioma cells in\u00a0vitro and in\u00a0vivo","volume":"66","author":"Kawaguchi","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.biochi.2012.03.007_bib31","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1126\/science.7512751","article-title":"Requirement of vascular integrin alpha v beta 3 for angiogenesis","volume":"264","author":"Brooks","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.biochi.2012.03.007_bib32","doi-asserted-by":"crossref","first-page":"9764","DOI":"10.1073\/pnas.93.18.9764","article-title":"Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases","volume":"93","author":"Friedlander","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1016\/j.biochi.2012.03.007_bib33","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1034\/j.1399-3011.2003.00085.x","article-title":"Using protein-based motifs to stabilize peptides","volume":"62","author":"Walker","year":"2003","journal-title":"J.\u00a0Peptide. Res."},{"key":"10.1016\/j.biochi.2012.03.007_bib34","doi-asserted-by":"crossref","first-page":"15040","DOI":"10.1073\/pnas.0807055105","article-title":"Identification of amino acids essential for the antiangiogenic activity of tumstatin and its use in combination antitumor activity","volume":"105","author":"Eikesdal","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1016\/j.biochi.2012.03.007_bib35","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/BF02631356","article-title":"Human microvessel endothelial cells: isolation, culture and characterization","volume":"29","author":"Hewett","year":"1993","journal-title":"In\u00a0Vitro Cell. Dev. Biol. Anim."}],"container-title":["Biochimie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300908412000995?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300908412000995?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T06:00:47Z","timestamp":1687327247000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300908412000995"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0300908412000995"],"URL":"https:\/\/doi.org\/10.1016\/j.biochi.2012.03.007","relation":{},"ISSN":["0300-9084"],"issn-type":[{"value":"0300-9084","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}